Previous 10 | Next 10 |
STAAR Surgical (NASDAQ: STAA ): Q1 Non-GAAP EPS of $0.04 beats by $0.01 ; GAAP EPS of $0.00 beats by $0.04 . More news on: STAAR Surgical Company, Earnings news and commentary, Consumer stocks news, Read more ...
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the first quarter ended April 3, 2020. First Quarter 2020 Overview Net Sales of $35.2 Mill...
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today announced that it will release financial results for the first quarter ended April 3, 2020 on Wednesday, May 6, 2020 after the ...
Citing COVID-19 disruptions, STAAR Surgical (NASDAQ: STAA ) is withdrawing its outlook for fiscal 2020. More news on: STAAR Surgical Company, Healthcare stocks news, , Read more ...
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today provided a business update relating to the evolving COVID-19 global health care concern. “We have made the decision to get o...
In this episode of Industry Focus: Wildcard , Jason Moser and Motley Fool contributor Brian Feroldi give a breakdown of three great small caps you probably didn't know about. They range from a service provider to a surgical company and finally a research and consultancy firm. Find out wh...
STAAR Surgical Company (STAA) Q4 2019 Earnings Conference Call February 26, 2020 16:30 ET Company Participants Brian Moore - Senior Director, Investor, Media Relations & Corporate Development Caren Mason - President & CEO Deborah Andrews - CFO Conference Call Participa...
Image source: The Motley Fool. Staar Surgical Co (NASDAQ: STAA) Q4 2019 Earnings Call Feb 26, 2020 , 4:30 p.m. ET Operator Continue reading
STAAR Surgical (NASDAQ: STAA ): Q4 Non-GAAP EPS of $0.12 beats by $0.02 ; GAAP EPS of $0.14 beats by $0.10 . More news on: STAAR Surgical Company, Earnings news and commentary, Consumer stocks news, Read more ...
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, today reported financial results for the fourth quarter and fiscal year ended January 3, 2020. Fourth Quarter 2019 Overview Net...
News, Short Squeeze, Breakout and More Instantly...
STAAR Surgical Company Company Name:
STAA Stock Symbol:
NASDAQ Market:
STAAR Surgical Company Website:
2024-07-14 17:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, invites investors and the general public to listen to a webcast fireside chat with Patrick F. Will...
2024-05-24 07:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...